Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 32 % of short-term debt in 2024; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 0.4 to 0.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
PHARMACIE ANANGA-TALOM from Charleroi, company number BE0452425222, closed financial year 2024 with a result of € 11,219 after tax. For that financial year PHARMACIE ANANGA-TALOM recorded a gross margin of € 35,478 and equity of € 203,417. Compared with financial year 2023, the result moved from € -20,278 to € 11,219. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on December 12, 2024.
€ 203,417
▲ 6% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 11,219
▲ still € 20,278 loss in 2023
Profit after tax over the fiscal year.
€ 582
▼ 84% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 184,817.
People and assets in 2024
0
▼ 0.3 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 10,157
▼ 14% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 956
▼ 41% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 58,871
▲ 40% vs 2023
Loans from banks and other lenders, long and short.
€ 370,608
▲ 128% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 1,593
▼ 71% vs 2023
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 25,642 | € -15,859 | € 35,478 | ▲ € 51,337 |
| Profit after taxes | € 14,607 | € -20,278 | € 11,219 | ▲ € 31,497 |
| Equity | € 212,476 | € 192,198 | € 203,417 | ▲ 6% |
| Total debts | € 308,422 | € 323,504 | € 533,593 | ▲ 65% |
| Cash | € 13,262 | € 3,581 | € 582 | ▼ 84% |
| Retained profit | € 193,876 | € 173,598 | € 184,817 | ▲ 6% |
| Bank debt | € 37,721 | € 42,198 | € 58,871 | ▲ 40% |
| Balance sheet total | € 520,899 | € 515,702 | € 737,011 | ▲ 43% |
| Employees (FTE) | 0.4 | 0.3 | 0 | ▼ 0.3 |
Key figures of PHARMACIE ANANGA-TALOM, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 October 2025.
What happened to PHARMACIE ANANGA-TALOM?
What happened at PHARMACIE ANANGA-TALOM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
PHARMACIE ANANGA-TALOM is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2024: profit of € 11,219. filed late Source: NBB ↗
- Claude-Valérie Ananga became a director. NBB
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 14,607 profit in 2022 to € 11,219 profit in 2024.
Paid € 6,012 in corporate taxes since 2022.
Best year ever: 2022, with € 14,607 profit.
A new publication or filing at PHARMACIE ANANGA-TALOM? We notify you, reason included.
Follow PHARMACIE ANANGA-TALOMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ALPHAR MONCEAU SUR SAMBRE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE ANANGA-TALOMBehind PHARMACIE ANANGA-TALOM is Claude-Valérie Ananga. The shares are held by ALPHAR MONCEAU SUR SAMBRE (100%).
Directors
According to the 2024 annual accounts
since 2010
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue Jules Destrée 18
6031 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0452.425.222
- VAT number
- BE 0452.425.222
- Registered office
- Avenue Jules Destrée 18, 6031 Charleroi
- Names & denominations
- PHARMACIE ANANGA-TALOM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 31 March 1994
- Peppol
- Not registered
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers